Ming-Chin Yu

20PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMolecular targetsTraditional Chinese medicine and treatmentsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 01, 2026
Machine-Learning Based Prognostic Model for Predicting Early Recurrence in HCC Patients After Hepatectomies: An Explainable AI Approach.

|Jan 03, 2026
SOX4-STAT6-MTHFD2 axis drives hepatocellular carcinoma progression and treatment resistance.

Chia-Lung Tsai, Ming-Chin Yu, Cheng-Lung Hsu

|Jan 01, 2026
Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha-Fetoprotein-Negative Patients With Cirrhotic Nodules.

Li-Jun Chang, Ming-Chin Yu, Wei-Chen Lee

|Oct 15, 2025
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.

Hsin-Chou Yang, Pui-Yan Kwok, Ling-Hui Li

|Aug 26, 2025
NRF2-SOX4 complex regulates PSPH in hepatocellular carcinoma and modulates M2 macrophage differentiation.

Chi-Neu Tsai, Ming-Chin Yu, Yun-Shien Lee

|Apr 28, 2025
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.

Sheue-Fen Tzeng, Yi-Ru Yu, Jaeoh Park

Pageof 4

Frequent Collaborators

6 joint publications

Chao-Wei Lee

6 joint publications

Sey-En Lin

5 joint publications

Heng-Yuan Hsu

3 joint publications

Tsung-Han Wu